$ACCD
Accolade, Inc.

2022 Q2 Form 10-Q Financial Statement

#000155837022010499 Filed on July 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q2
Revenue $85.53M $93.76M $59.53M
YoY Change 43.68% 58.29% 65.84%
Cost Of Revenue $47.62M $43.59M $35.94M
YoY Change 32.5% 57.83% 61.58%
Gross Profit $37.91M $50.16M $23.59M
YoY Change 60.71% 58.69% 72.7%
Gross Profit Margin 44.33% 53.5% 39.63%
Selling, General & Admin $45.85M $75.46M $36.51M
YoY Change 25.58% 120.33% 181.24%
% of Gross Profit 120.94% 150.42% 154.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.58M $11.64M $8.696M
YoY Change 33.12% 448.59% 351.04%
% of Gross Profit 30.53% 23.21% 36.86%
Operating Expenses $384.0M $79.96M $71.61M
YoY Change 436.2% 119.86% 172.47%
Operating Profit -$346.0M -$29.80M -$48.02M
YoY Change 620.69% 526.2% 280.32%
Interest Expense -$634.0K -$768.0K -$618.0K
YoY Change 2.59% 1159.02% -51.79%
% of Operating Profit
Other Income/Expense, Net -$50.00K -$114.0K -$55.00K
YoY Change -9.09% -976.92% 266.67%
Pretax Income -$346.7M -$30.69M -$48.69M
YoY Change 612.13% 538.53% 249.72%
Income Tax -$3.899M $3.862M $19.00K
% Of Pretax Income
Net Earnings -$342.8M -$34.56M -$48.71M
YoY Change 603.85% 631.19% 248.9%
Net Earnings / Revenue -400.83% -36.86% -81.82%
Basic Earnings Per Share -$4.92 -$0.84
Diluted Earnings Per Share -$4.92 -$513.9K -$0.84
COMMON SHARES
Basic Shares Outstanding 69.74M 58.26M
Diluted Shares Outstanding 69.74M 58.26M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $335.6M $365.9M $425.5M
YoY Change -21.12% -15.68% 447.63%
Cash & Equivalents $335.6M $365.9M $325.5M
Short-Term Investments $100.0M
Other Short-Term Assets $13.46M $12.48M $9.929M
YoY Change 35.57% 51.13% -37.55%
Inventory
Prepaid Expenses
Receivables $21.74M $21.12M $15.31M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $377.6M $409.1M $453.5M
YoY Change -16.74% -9.88% 368.67%
LONG-TERM ASSETS
Property, Plant & Equipment $11.87M $11.80M $12.16M
YoY Change -2.4% 27.85% -3.5%
Goodwill $278.2M $577.9M $214.2M
YoY Change 29.89% 14300.6% 5237.08%
Intangibles $234.3M $244.7M $203.5M
YoY Change 15.15% 40411.59% 11927.07%
Long-Term Investments
YoY Change
Other Assets $1.575M $1.678M $1.752M
YoY Change -10.1% 3.71% 32.53%
Total Long-Term Assets $566.9M $876.4M $438.0M
YoY Change 29.42% 3970.75% 1746.07%
TOTAL ASSETS
Total Short-Term Assets $377.6M $409.1M $453.5M
Total Long-Term Assets $566.9M $876.4M $438.0M
Total Assets $944.5M $1.286B $891.5M
YoY Change 5.94% 170.35% 639.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.777M $7.837M $7.089M
YoY Change 9.71% 6.05% 43.5%
Accrued Expenses $39.72M $11.00M $7.498M
YoY Change 429.67% 103.25% 71.38%
Deferred Revenue $36.88M $30.88M $32.91M
YoY Change 12.08% 19.31% -4.46%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $95.48M $111.8M $167.5M
YoY Change -42.99% 41.33% 122.15%
LONG-TERM LIABILITIES
Long-Term Debt $281.1M $280.7M $279.4M
YoY Change 0.59% 285.43%
Other Long-Term Liabilities $563.0K $4.562M $7.462M
YoY Change -92.46% -18.35% 24.37%
Total Long-Term Liabilities $563.0K $4.562M $286.9M
YoY Change -99.8% -18.35% 265.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $95.48M $111.8M $167.5M
Total Long-Term Liabilities $563.0K $4.562M $286.9M
Total Liabilities $409.9M $429.7M $454.4M
YoY Change -9.78% 407.59% 195.14%
SHAREHOLDERS EQUITY
Retained Earnings -$837.5M -$494.6M -$420.2M
YoY Change 99.29% 33.14% 25.51%
Common Stock $7.000K $7.000K $6.000K
YoY Change 16.67% 16.67% 200.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $534.5M $855.8M $437.1M
YoY Change
Total Liabilities & Shareholders Equity $944.5M $1.286B $891.5M
YoY Change 5.94% 170.35% 639.94%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q2
OPERATING ACTIVITIES
Net Income -$342.8M -$34.56M -$48.71M
YoY Change 603.85% 631.19% 248.9%
Depreciation, Depletion And Amortization $11.58M $11.64M $8.696M
YoY Change 33.12% 448.59% 351.04%
Cash From Operating Activities -$30.46M -$2.284M -$27.61M
YoY Change 10.31% -121.97% 232.02%
INVESTING ACTIVITIES
Capital Expenditures $506.0K -$701.0K $701.0K
YoY Change -27.82% 41.62% 181.53%
Acquisitions $228.0M
YoY Change
Other Investing Activities $0.00 $169.0K -$328.0M
YoY Change -100.0% 8350.0%
Cash From Investing Activities -$1.272M -$532.0K -$328.7M
YoY Change -99.61% 7.91% 60998.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.508M 2.687M 248.0M
YoY Change -99.39% -46.73% 364.48%
NET CHANGE
Cash From Operating Activities -30.46M -2.284M -27.61M
Cash From Investing Activities -1.272M -532.0K -328.7M
Cash From Financing Activities 1.508M 2.687M 248.0M
Net Change In Cash -30.23M -129.0K -108.4M
YoY Change -72.11% -100.86% -343.39%
FREE CASH FLOW
Cash From Operating Activities -$30.46M -$2.284M -$27.61M
Capital Expenditures $506.0K -$701.0K $701.0K
Free Cash Flow -$30.97M -$1.583M -$28.32M
YoY Change 9.37% -114.53% 230.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.92
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69738638
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58261233
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67098477
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69610341
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 accd Deferred Acquisition Costs Non Current
DeferredAcquisitionCostsNonCurrent
7205000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1678000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1575000
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0969591
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001481646
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 accd Goodwill Impairment Adjustment Per Shares Diluted
GoodwillImpairmentAdjustmentPerSharesDiluted
4.30
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-05-31
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-39348
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
ACCOLADE, INC.
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
1201 Third Avenue
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1700
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
CY2022Q2 dei City Area Code
CityAreaCode
206
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
926-8100
CY2022Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2022Q2 dei Trading Symbol
TradingSymbol
ACCD
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71209436
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
335628000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
365853000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21739000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21116000
CY2022Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
6739000
CY2022Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
9685000
CY2022Q2 accd Deferred Acquisition Costs Current
DeferredAcquisitionCostsCurrent
3179000
CY2022Q1 accd Deferred Acquisition Costs Current
DeferredAcquisitionCostsCurrent
3015000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10282000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9468000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
377567000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
409137000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11865000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11797000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33790000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33126000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1508000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
234318000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
244690000
CY2022Q2 accd Deferred Acquisition Costs Non Current
DeferredAcquisitionCostsNonCurrent
7148000
CY2022Q2 us-gaap Goodwill
Goodwill
278191000
CY2022Q1 us-gaap Goodwill
Goodwill
577896000
CY2022Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
22954000
CY2022Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
39189000
CY2022Q2 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
11104000
CY2022Q1 us-gaap Liabilities
Liabilities
429735000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Assets
Assets
944454000
CY2022Q1 us-gaap Assets
Assets
1285529000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7777000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7837000
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
9745000
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
11000000
CY2022Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
16263000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
36883000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30875000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7016000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6589000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
95479000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
111753000
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
281083000
CY2022Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
280666000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32542000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32486000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
563000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4562000
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
280000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
268000
CY2022Q2 us-gaap Liabilities
Liabilities
409947000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69610341
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67098477
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1371966000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1350431000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-837466000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-494644000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
534507000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
855794000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
944454000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1285529000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85528000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59527000
CY2022Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
47615000
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
35936000
CY2022Q2 accd Product And Technology Expense
ProductAndTechnologyExpense
26817000
CY2021Q2 accd Product And Technology Expense
ProductAndTechnologyExpense
15939000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11576000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8696000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25614000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14509000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20238000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22002000
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
299705000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
10460000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
383950000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
71606000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-346037000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-48015000
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-634000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-618000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-50000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-55000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-346721000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48688000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3899000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-342822000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-48707000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.92
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69738638
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58261233
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
390848000
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
116187000
CY2021Q2 accd Issuance Of Replacement Awards In Connection With Acquisition
IssuanceOfReplacementAwardsInConnectionWithAcquisition
1520000
CY2021Q2 accd Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
2141000
CY2021Q2 accd Adjustments To Additional Paid In Capital Capped Calls Purchased
AdjustmentsToAdditionalPaidInCapitalCappedCallsPurchased
34503000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1948000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7675000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-48707000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
437109000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
855794000
CY2022Q2 accd Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
358000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1788000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19389000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-342822000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
534507000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-342822000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-48707000
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
299705000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11576000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8696000
CY2022Q2 accd Amortization Of Deferred Contract Acquisition Costs
AmortizationOfDeferredContractAcquisitionCosts
817000
CY2021Q2 accd Amortization Of Deferred Contract Acquisition Costs
AmortizationOfDeferredContractAcquisitionCosts
602000
CY2021Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
10460000
CY2022Q2 accd Deferred Income Tax Expense Benefit Related To Acquisition
DeferredIncomeTaxExpenseBenefitRelatedToAcquisition
3999000
CY2022Q2 us-gaap Paid In Kind Interest
PaidInKindInterest
419000
CY2021Q2 us-gaap Paid In Kind Interest
PaidInKindInterest
379000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
19389000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7675000
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
506000
CY2022Q2 accd Increase Decrease In Accounts Receivable And Unbilled Revenue
IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue
-2323000
CY2021Q2 accd Increase Decrease In Accounts Receivable And Unbilled Revenue
IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue
409000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1258000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
268000
CY2022Q2 accd Increase Decrease In Deferred Contract Acquisition Costs
IncreaseDecreaseInDeferredContractAcquisitionCosts
924000
CY2021Q2 accd Increase Decrease In Deferred Contract Acquisition Costs
IncreaseDecreaseInDeferredContractAcquisitionCosts
507000
CY2022Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
862000
CY2021Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7643000
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15598000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13247000
CY2022Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-240000
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-82000
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
711000
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
385000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30461000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27614000
CY2021Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
99998000
CY2022Q2 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
766000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
701000
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
228013000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1272000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-328712000
CY2022Q2 accd Proceeds From Stock Option And Warrant Exercises
ProceedsFromStockOptionAndWarrantExercises
358000
CY2021Q2 accd Proceeds From Stock Option And Warrant Exercises
ProceedsFromStockOptionAndWarrantExercises
1991000
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
23000
CY2021Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8101000
CY2021Q2 accd Payment For Purchase Of Capped Calls
PaymentForPurchaseOfCappedCalls
34443000
CY2022Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1150000
CY2021Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1026000
CY2021Q2 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
287500000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
247950000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30225000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-108376000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
365853000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
433884000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
335628000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
325508000
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
769000
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
51000
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
228000
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
292000
CY2022Q2 accd Other Receivable Related To Stock Option Exercises
OtherReceivableRelatedToStockOptionExercises
5000
CY2021Q2 accd Other Receivable Related To Stock Option Exercises
OtherReceivableRelatedToStockOptionExercises
247000
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22000
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
31000
CY2021Q2 us-gaap Stock Issued1
StockIssued1
116187000
CY2022Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q2 accd Replacement Awards Issued In Connection With Acquisition
ReplacementAwardsIssuedInConnectionWithAcquisition
1520000
CY2021Q2 accd Offering Costs Included In Accounts Payable And Accrued Expenses
OfferingCostsIncludedInAccountsPayableAndAccruedExpenses
304000
CY2021Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;"> (</span><span style="font-style:italic;">h</span><span style="font-style:italic;">)  Concentration of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and marketable securities. The Company maintains its cash primarily with domestic financial institutions of high credit quality, which may exceed federal deposit insurance corporation limits. The Company invests its cash equivalents in highly rated money market funds. Marketable securities are comprised of United States treasury bills with original maturities greater than 90 days. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Significant customers are those which represent 10% or more of the Company’s revenue during the periods. For each significant customer, revenue as a percentage of total revenue was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:75.22%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:48.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="border-bottom-style:solid;border-bottom-width:0.5pt;font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:double;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:42.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the three months ended May 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="border-bottom-style:solid;border-bottom-width:0.5pt;font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:double;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:48.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">*For the three months ended May 31, 2022, no customer represented 10% or more of the Company’s revenue.</p>
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34739000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
38740000
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
85528000
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59527000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
243744000
CY2021Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1410000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
243744000
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
24447000
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18925000
CY2022Q1 us-gaap Goodwill
Goodwill
577896000
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
299705000
CY2022Q2 us-gaap Goodwill
Goodwill
278191000
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
299705000
CY2022Q2 accd Goodwill Impairment Adjustment Per Shares Basic
GoodwillImpairmentAdjustmentPerSharesBasic
4.30
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q2 accd Goodwill Impairment Test Discount Rate
GoodwillImpairmentTestDiscountRate
0.11
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
127326000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
73836000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
39813000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2769000
CY2022Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1829000
CY2022Q2 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P5Y
CY2021Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2021Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
72532000
CY2021Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-63099000
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
8380000
CY2022Q2 accd Goodwill Impairment Test For Current Revenue
GoodwillImpairmentTestForCurrentRevenue
1.1
CY2022Q2 accd Goodwill Impairment Test For Forward Revenue
GoodwillImpairmentTestForForwardRevenue
1.8
CY2022Q2 accd Excess Of Fair Value Over Carrying Value
ExcessOfFairValueOverCarryingValue
0
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
283576000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49258000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
234318000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10372000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6605000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1949000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1760000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
430000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
344000
CY2022Q2 us-gaap Lease Cost
LeaseCost
2379000
CY2021Q2 us-gaap Lease Cost
LeaseCost
2104000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2128000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2036000
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2155000
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2367000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8860000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7281000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7248000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6318000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
9405000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
45779000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6221000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
39558000
CY2022Q2 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
185265000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6667000
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
1425000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19389000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7675000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3899000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.011
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3899000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-342822000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-48707000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69738638
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58261233
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.92
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17679041
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17148033
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
888000
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
40323000
CY2022Q2 accd Purchase Obligation Remaining Future Purchase Commitments
PurchaseObligationRemainingFuturePurchaseCommitments
36736000

Files In Submission

Name View Source Status
0001558370-22-010499-index-headers.html Edgar Link pending
0001558370-22-010499-index.html Edgar Link pending
0001558370-22-010499.txt Edgar Link pending
0001558370-22-010499-xbrl.zip Edgar Link pending
accd-20220531.xsd Edgar Link pending
accd-20220531x10q.htm Edgar Link pending
accd-20220531x10q_htm.xml Edgar Link completed
accd-20220531xex10d1.htm Edgar Link pending
accd-20220531xex31d1.htm Edgar Link pending
accd-20220531xex31d2.htm Edgar Link pending
accd-20220531xex32d1.htm Edgar Link pending
accd-20220531_cal.xml Edgar Link unprocessable
accd-20220531_def.xml Edgar Link unprocessable
accd-20220531_lab.xml Edgar Link unprocessable
accd-20220531_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending